Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 102.60
-1.80 (-1.72%)
Jan 21, 2026, 12:48 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.74 billion as of January 21, 2026. Its market cap has decreased by -11.13% in one year.
Market Cap
1.74B
Enterprise Value
1.71B
Revenue
242.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
102.60
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.74B, an increase of 28.62%. That is a compound annual growth rate of 6.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.74B | -8.58% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 112.22B |
| Getinge AB | 57.22B |
| Sectra AB | 43.89B |
| BioArctic AB | 43.86B |
| Cereno Scientific AB | 1.97B |
| BioInvent International AB | 1.87B |
| Carasent AB | 1.81B |
| Egetis Therapeutics AB | 1.77B |